untitled

Size: px
Start display at page:

Download "untitled"

Transcription

1

2

3 JECFA...15 FDA...15 (EU)

4 1

5 CAS JECFA 1970 ADI not specified ADI 2

6 1 GRAS GMPGood Manufacturing Practice 2% 5% 1) 2) EU 10 g/kg 10 g/kg dietary food supplement 3) FAO/WHO JECFA EU JECFA PTWI JECFA 2 3

7 2% 2% Calcium silicate 4)-10) CAS CaOSiO 2 Calcium metasilicatecasio Calcium orthosilicateca 2 SiO Tricalcium silicateca 3 SiO ) SiO % CaO % 6) JECFA ADI not limited 7)-19) 7)-10), 14), 16) Magnesium silicatesynthetic CAS ) MgO % 67.0% 14), 16) 4

8 Magnesium trisilicate2mgo3sio 2 XH 2 O Sodium aluminosilicate CAS ), 12), 17), 18) xna 2 OyAl 2 O 3 zsio 2 nh 2 O xy z 1:1:13 Sodium aluminium orthosilicate NaAlSiO Sodium aluminium silicate Al 2 O 3 Na 2 O6SiO ) SiO % Al 2 O % Na 2 O % 17) Aluminium calcium silicate 7), 8), 13), 18) CAS wna 2 OxCaO yal 2 O 3 zsio Calcium aluminium orthosilicate CaAl 2 Si 2 O Calcium dialuminoorthosilicate Ca 3 Al 2 SiO 3 Calcium dialumino metasilicate (AlOOCa) 2 SiO 3 13) SiO %Al 2 O %CaO %Na 2 O % 13) 5

9 1 2 SiO %Al 2 O % 9), 19) (b) JECFA hydrated aluminium silicate 11) M 2/n OAl 2 O 3 y SiO 2 wh 2 OM n y 2 2 A Na 12 [(AlO 2 ) 12 (SiO 2 ) 12 ] 27H 2 O 8), 9), 19),20) SiO %MgO 30.5% 8), 18), 19) (b) JECFA magnesium silicates 11), 15) SiO 2 [ H 2 SiO 3 ] 8), 9),18) [Si(OH) 4 ] H 2 SiO 3 SiO 2 nh 2 O 8),18) 6

10 (a) 5 g 20 ml mg SiO mg SiO 2 21) (b) 5 g 20 ml mg SiO 2 5 g9.2 mg SiO mg SiO 2 21) mg/kg 22) ,000 mg/kg / mg/kg / 16.8% 23) g g g mmol ) mg/kg / A30 mg/kg / (p<0.05) A AUC 22) 4 A ,000 mg/kg / 40 mg/kg 1.2% A 12.1% 72 7

11 23) 5 g 20 ml mg SiO mg SiO 2 21) 25)-27) 100 ppm Si(OH) 4 28), 29) 28) Yokoi Enomoto 28) 30) 24) 31) 32), 26) 1 µg/ml 32) 0.5 µg/ml 32), 33) µg/ ml (n=15) 34) 1 µg SiO 2 / ml 27) 8

12 33) 34) 25) mg SiO 2 /100 ml (n=6) (n=2) (n=6) (n=7) (n=6) (n=3) 35) 20.12±6.40 mg Si/(n=8) 36) 8.7±4.2 mg Si/ 36) 33.1±3.9 mg Si/ 36) mg Si(OH) 4 / 37) 32) 37) ml/ 2 ml/ 190 µg/ml1 mg/ml ) 39) 40) 100% 39)-41) 9

13 35), 42) 2 (a) ,2004,0005,000 mg/kg 5,000 mg/kg 1030 LD 50 5,000 mg/kg 43), 44) %(W/V) 5,000 mg/kg7 LD 50 5,000 mg/kg 20) ,0002,000 3,0004,0005,000 mg/kg 5,000 mg/kg 24 LD 50 3,400 mg/kg 20) (b) LD 50 1,050 mg/kg 45) (a) 25 mg 46) 10

14 10 mg/m ) (b) % ,250 mg/kg / % 1% 37) %50 mg/125 mg/kg / ) %05001,500 2,500 mg/kg / 1 3.0% 90 5% 37) mg/kg / 2 37) %01,875 3,7507,500 mg/kg / ) %06251,2502,500 mg/kg / JECFA 48) (kg) (g//) (g/kg /)

15 % 47) g/kg /1.3 g/kg / 2.4 g/kg /1.8 g/kg / 4 37), 49) JECFA 1973 ADI not limited ADI not limited 50) (a) ,600 mg/kg / 45) ,0001,250 1,500 1,600 mg/kg / 29 1,600 mg/kg / 13 20), 45) (b) 1,600 mg/kg /1,200 mg/kg /900 mg/kg / 12

16 45) 100 mg/kg / ) (a) Salmonella typhimurium TA1530 G46 Saccharomyces cerevisiae D ,5005,000 mg/kg 5 in vitro 51) µg/ml µg/ml 52) WI µg/ml 51) ,5005,000 mg/kg ) ,5005,000 mg/kg 5 51) (b) S. typhimurium TA98, TA100, TA1535, TA1537, TA1538 Escherichia coli WP mg/plates9 mix 53) S. typhimurium TA98, TA100, TA1535, TA1537, TA1538E. coli WP mg/plates9 mix 13

17 53) S. typhimurium TA1530 G46 S. cerevisiae D ,000 mg/kg 5 in vitro 54) WI µg/ml 54) ,000 mg/kg ) ,000 mg/kg 5 54) S. typhimurium TA98, TA100, TA1535, TA1537, TA1538 E. coli WP mg/plates9 mix 53) 55) 12% g/ 34 11,000 37) g 37) ), 56) 20 40) ) 14

18 mg Si/l 41) JECFA ADI not limited 11) ) ADI not limitedjecfa ADI not limitedadi ADI not specifiedadi 50), 37) ADI 58) ADI not specifiedadi 30) JECFA ADI 48) ADI FDA FDA GRAS 1979 FDA

19 45) EU SCF 1990 ADI ADI not specified EFSA kg 2050 mg mg/kg / 55% 55) 131 ppm8.2 ppm 22.5 ppm 2.0 ppm7.1 ppm 27) NAS/NRC ) 3 mg// 0.5 mg// 18 mg// ) 60 kg 9.8 mg// 16

20 7.3 mg// 0.5 mg(al )// mg mg 60) ADI 61) mg 62) 20 mg/l 63) JECFA 1970 ADI not specified ADI 17

21 1) Food and Drug Administration, HHS. 21CFR, Subpart C -Anticaking Agents Aluminum calcium silicate, Calcium silicate, Magnesium silicate, Sodium aluminosilicate. 21CFR Ch.I ( Edition). 2) Food and Drug Administration, HHS. 21CFR, Subpart E -Anticaking Agents, Calcium Silicate. 21CFR Ch I. ( Edition). 3) Office for Official Publications of the EC. European parliament and council directive No 95/2/EC of 20 February 1995 on food additives other than colours and sweeteners. CONSLEG: 1995L /07/2003, pp.1-7, ) Compedium of calcium silicate. Prepared at the 17th JECFA (1973), Published in FNP 4 (1978) and in FNP 52 (1992). 5) Institute of Medicine of the National Academies. FCC V Monographs /Calcium Silicate. Food Chemicals Codex : ) Official Journal of the European Communities. Commission Directive 2000/63/EC of October Amending directive 96/77/EC/ laying down specific purity criteria on food additives other than colours and sweeteners (. O J L277/1-4, L277/ ).. 9.(1993) : 103, 104, 302, 303, ) Calcium Aluminosilicate, Calcium Silicate, Kaolin, Magnesium Silicate, Silicon Dioxide, Talc, Zeolites. THE MERCK INDEX, Thirteenth Edition. (2001):277, 284, 945, , , 1613, ). Calcium SilicateSilica Gel) Zeolite)(Magnesium Trisilicate) Silicon DioxideFine))Kaolin) (2005): 16-17, , 184, , ). ph. ( No.Q-0456). 11) Thirteenth Report of the JECFA. Specifications for the identity and purity of food additives and their toxicological evaluation. WHO Technical Report Series 445, FAO Nutrition Meetings Report Series 46. (1970). 12) Compedium of sodium aluminosilicate. Prepared at the 17th JECFA (1973), Published in FNP 4 (1978) and in FNP 52 (1992). 13) Compedium of calcium aluminium silicate. Prepared at the 28th JECFA (1984), Published in FNP 31/2 (1984) and in FNP 52 (1992). 14) Compedium of magnesium silicate (synthetic). Prepared at the 61th JECFA (2003), Published in FNP 52 Add 11 (2003). 18

22 15) JECFA. Toxicological evaluation of some food colours, emulsifiers, stabilizers, anti-caking agents and certain other substances. FAO Nutrition Meetings Report Series 46A WHO/FOOD ADD/ (1969). 16) Institute of Medicine of the National Academies. FCC V Monographs /Magnesium Silicate. Food Chemicals Codex : ) Institute of Medicine of the National Academies. FCC V Monographs /Sodium Aluminosilicate. Food Chemicals Codex : ). 4. (1987): 51, , 239, , 495, ).. (1999): 130, 316, ) Cosmetic Ingredient Review Expert Panel. Final report on the safety assessment of aluminum silicate, calcium silicate, magnesium aluminum silicate, magnesium silicate, magnesium trisilicate, sodium magnesium silicate, zirconium silicate, attapulgite, bentonite, Fuller's earth, hectorite, kaolin, lithium magnesium silicate, lithium magnesium sodium silicate, montmorillonite, pyrophyllite, and zeolite. Int. J. Toxicol. (2003) 22: ) King EJ, McGeorge M. The biochemistry of silicic acid. : The solution and excretion of silica. Biochem. J. (1938) 32: ) Cefali EA, Nolan JC, McConnell WR, Walters DL. Pharmacokinetic study of zeolite A, sodium aluminosilicate, magnesium silicate, and aluminum hydroxide in dogs. Pharm. Res. (1995) 12: ) Benke GM, Osborn TW. Urinary silicon excretion by rats following oral administration of silicon compounds. Food Cosmet. Toxico. (1979) 17: ) Dobbie JW, Smith MB. Silicate nephrotoxicity in the experimental animal: the missing factor in analgesic nephropathy. Scott. Med. J. (1982) 27: ) Bellia JP, Birchall JD, Roberts NB. Beer: a dietary source of silicon. The Lancet. (1994) 343: ) Calomme MR, Vanden Berghe DA. Supplementation of calves with stabilized orthosilicic acid. Effect on the Si, Ca, Mg, and P concentrations in serum and the collagen concentration in skin and cartilage. Biol. Trace Elem. Res. (1997) 56: ) Baumann H. Verhalten der kieselsäure im menschlichen blut und harn. Z Physiol Chemie. (1960) 320: ) Yokoi H, Enomoto S. Effect of degree of polymerization of silicic acid on the gastrointestinal absorption of silicate in rats. Chem. Pharm. Bull. (1979) 27: ) Meyers P. Behavior of silica - technologies available and how they rate. Water Conditioning & Purificationl (2004) 46: ) Twenty-ninth Report of the JECFA. Evaluation of certain food additives and 19

23 contaminants. WHO Technical Report Series 733. (1986). 31) SECTION 9: Reactions to Environmental Agents. HANDBOOK OF PHYSIOLIGY, American Physiological Society, BETHESDA, MARYLAND (1977) : ) Carlisle EM. Silicon. Biochemistry of the Essential NY: Plenum Press. (1984): ) Carlisle EM. Silicon as a trace nutrient. The Sci.Total Environ. (1988) 73: ) Saldanha LF, Gonick HC, Rodriguez HJ, Marmelzat JA, Repique EV, Marcus CL. Silicon-related syndrome in dialysis patients. Nephron. (1997) 77: ) King EJ, Stantial H, Dolan M. The biochemistry of silicic acid.. The presence of silica in tissues. Biochem. J. (1933) 27: ) Reffitt DM, Jugdaohsingh R, Thompson RP, Powell JJ. Silicic acid: its gastrointestinal uptake and urinary excretion in man and effects on aluminium excretion. J. Inorg. Biochem. (1999) 76: ) JECFA. Toxicological evaluation of some food additives including anticaking agents, antimicrobials, antioxidants, emulsifiers and thickening agents. WHO Food Additives Series 5. (1974): ) Baily CB. Silica metabolism and silica urolithiasis in ruminants: A review. J. Anim. Sci. (1981) 61: ) Farrer JH, Rajfer J. Silicate urolithiasis. J. Urol. (1984) 132: ) Haddad FS, Kouyoumdjian A. Silica stones in humans. Uro. Int. (1986) 41: ) Nishizono T, Eta S, Enokida H, Nishiyama K, Kawahara M, Nakagawa M. Renal silica calculi in an infant. In. J. Uro. (2004) 11: ) Carlisle EM. Silicon: an essential element for the chick. Science. (1972) 178: ). R. No. T ( ). 44). R. No. T ( 11 9 ). 45) FDA. Evaluation of the health aspects of certain silicates as food ingredients. National Technical Information Service (NTIS), PB FDA Contract No /2004. (1979). 46) Bolton RE, Addison J, Davis JM, Donaldson K, Jones AD, Miller BG, Wright A. Effects of the inhalation of dusts from calcium silicate insulation materials in laboratory rats. Environ. Res. (1986) 39: ) Takizawa Y, Hirasawa F, Noritomi E, Aida M, Tsunoda H. Oral ingestion of SYLOID to mice and rats and its chronic toxicity and carcinogenicity. Acta Medica et Biologica. (1988) 36: ) Principles for the safety assessment of food additives and contaminants in food. Environmental Health Criteria 70. IPCS in cooperation with the JECFA. World Health 20

24 Organization, Geneva. (1987). 49) Newberne PM, Wilson RB. Renal damage associated with silicon compounds in dogs. Proc. Nati. Acad. Sci. (1970) 65: ) Seventeenth Report of the JECFA. Toxicological evaluation of certain food additives with a review of general principles and of specification. WHO Technical Report Series 539, FAO Nutrition Meetings Report Series 53. (1974). 51) Litton Bionetics, Inc. Mutagenic evaluation of compound FDA 71-41, calcium silicate. National Technical Information Service (NTIS), PB (1974). 52) Aslam M, Rahman O. Cytotoxic and genotoxic effects of calcium silicates on human lymphocytes in vitro. Mutat. Res. (1993) 300: ) Prival MJ, Simmon VF, Mortelmans KE. Bacterial mutagenicity testing of 49 food ingredients gives very few positive results. Mutat. Res. (1991) 260: ) Litton Bionetics, Inc. Mutagenic evaluation of compound FDA 71-45, synthetic silica sodium silicoaluminate. National Technical Information Service (NTIS), PB (1974). 55) European Food Safety Authority (EFSA). Opinion of the scientific panel on dietetic products, nutrition and allergies on a request from the commission related to the tolerable upper intake level of silicon. The EFSA Journal. (2004) 60: ) Lee MH, Lee YH, Hsu TH, Chen MT, Chang LS. Silica stone - development due to long time oral trisilicate intake. Scand. J. Uro. Nephrol. (1993) 27: ) Ichiyanagi O, Sasagawa I, Adachi Y, Suzuki H, Kubota Y, Nakada T. Silica urolithiasis without magnesium trisilicate intake. Urol. Int. (1998) 61: ) Twenty-sixth Report of the JECFA. Evaluation of certain food additives and contaminants. WHO Technical Report Series 683. (1982). 59) Ministry of Agriculture, Fisheries and Food. Dietary Intake of Food Additives in the UK : Initial Surveillance. Food Surveillance Paper No ) Jugdaohsingh R, Anderson SH, Tucker KL, Elliott H, Kiel DP, Thompson RP, Powell JJ. Dietary silicon intake and absorption. Am. J. Clin. Nutr. (2002) 75: ) EU Commission. Report from the commission on dietary food additive intake in the European Union. ( 62) ).. (2002):

25 25 mg mg/kg 45 / , 4, 5 g/kg 5 g/kg 1030 LD 50 = 5 g/kg , 4, 5 g/kg 1030 LD 50 = 5 g/kg 5 g/kg 24.1% 7 20 LD 50 = 5 g/kg , 0.5, 1, 2, 3, 4, 5 g/kg 24 5g/kg LD 50 = 3.4 g/kg LD 50 = 1.05 g/kg , 0.2, 1.0, 2.5 % 1, 2.5% 37 ( ,250 mg/kg / 1) ) mg/ 37 (125 mg/kg / 1 ) , 1.0, 3.0, 5.0 % 37 (05001,5002,500 mg/kg / 1 ) mg/kg / 37 No , 1.25, 2.5, 5.0 % 5 g/kg (01,8753,750 7,500 mg/kg/ 1 ) , 1.25, 2.5, 5.0 % (06251,2502,500 mg/kg / 1 ) 2.5, 5.0 %12, Na 0.8 g/kg / Na Mg 37 Mg 1.3 g/kg / 0.8 g/kg / 49 Al 1.3 g/kg / 4 6 Na Mg 9 Al 1 10 mg/m mg/kg mg/kg 45 22

26 / 2 6 0, 250, 500, 750, ,000, 1,250, 1,500, 45 1,600 mg/kg mg/kg mg/kg mg/kg mg/kg mg/kg / In vitro TA1530 G46 D3 In vitro In vitro WI-38 TA1530 In vitro TA98 TA100 TA1535 TA1537 (+/ TA1538 S9mix) WP2 54In vitro TA98 TA100 TA1535 TA1537 (+/ TA1538 S9mix) WP2 In vitro G46 D3 No 15, 150, 1,500, 5, mg/kg µg/ml µg/ml , 10., 100µg/ml 51 15, 150, 1,500, 5,000 6, 24, 48 mg/kg 5 15, 150, 1,500, 5,000 mg/kg mg/ S9mix mg/ S9mix , 42.5, ,000 mg/kg In vitro WI-38 1, 10, 100 µg/ml 54 23

27 In vitro TA98 TA100 TA1535 TA1537 (+/ TA1538 S9mix) WP2 34 / , 42.5, , 24, ,000 mg/kg , 42.5, ,000 mg/kg % g/ 1/ mg/ S9mix 53 No g JECFA 48) (kg) (g//) (g/kg /)

HydroxypropylcelluloseCellulose 2-hydroxypropyl ether CH 2 OR R=H H O O H CH H 3 OR H CH 2 CH O m H OR m1 n 30,000n 100 1,000,000n 2,500 13) 1 14 C 14

HydroxypropylcelluloseCellulose 2-hydroxypropyl ether CH 2 OR R=H H O O H CH H 3 OR H CH 2 CH O m H OR m1 n 30,000n 100 1,000,000n 2,500 13) 1 14 C 14 HPC 1), 2), 3) HPC 4) 5) 6), 7), 8) GMPGood Manufacturing Practice EU 9) 10), 11) GMP 9) FAO/WHO JECFA 1989 35 7 HPC ADI not specified 12) 14 7 JECFA EU 46 HPC 16 8 16 EU - 1 - HydroxypropylcelluloseCellulose

More information

untitled

untitled 1 1 1 2 2 2 2 2 3 3 (1) 4 (2) 5 5 6 8 8 9 11 11 11 13 (1) JECFA 13 (2) FDA 13 (3) EU 13 (4) 2005 14 14 14 1 2005 15 2 2005 16 17 21 22 - 1 - Newberyite 50), 51), 52) Generally Recognized as SafeGRASGMP

More information

untitled

untitled 1 1 1 2 2 2 2 2 3 3 (1) 4 (2) 5 5 6 8 9 10 11 12 12 14 (1) JECFA 14 (2) FDA 14 (3) EU 14 (4) 2005 15 15 15 1 2005 16 2 2005 17 17 22 23 - 1 - Newberyite 50), 51), 52) Generally Recognized as SafeGRASGMP

More information

橡96-07.PDF

橡96-07.PDF 1 967 2482 CAS 50000 CH 2 O 30.03 2952% 12.5 % 1. 2) -92 2) -19.5 2) 5085 3) 424 3) 7.073.0% 4) 20 d 4 0.815 5) 1.03 ( = 1) 5) 1.33 kpa (10 mmhg) (-88.0) 2) log Pow0.35 ( ) 6) 0.35 ( ) 7) 1) m/z 29 ( 1.0

More information

,161 t 9,753 t 2,408 t LC 50 mg/ L EC 50 mg/l * 5 : Selenastrum 6772-h, Sb 2 O 3, : capricornutum 6 3 Selenastrum h, Sb

,161 t 9,753 t 2,408 t LC 50 mg/ L EC 50 mg/l * 5 : Selenastrum 6772-h, Sb 2 O 3, : capricornutum 6 3 Selenastrum h, Sb 1 20017 1543 CAS 1309644 125 Sb 2 O 3 291.52 1 99 1. 2 655 1,425 2 2 2 3 5.2 5.67 2 2 2. 10 12,161 t 9,753 t 2,408 t 4 3. 1 2 3 4. LC 50 mg/ L EC 50 mg/l * 5 : Selenastrum 6772-h, Sb 2 O 3, : capricornutum

More information

,309 t 22,069 t 7,240 t µg/l µg/l < ,431-70, , , mg/l m

,309 t 22,069 t 7,240 t µg/l µg/l < ,431-70, , , mg/l m 1 20019 1527 CAS 1317368 1230 PbO 223.20 1 99 1. 2 888 2 9.53 0.017 g/l 20 3 3 2 2. 10 29,309 t 22,069 t 7,240 t 4 1 3. 1 2 3.5 6 1 µg/l 9.1-24 2 µg/l < 43 6 27,431-70,000 4.5-1,300 13.4-17 31.7 0.48-3,459

More information

CAS O C O * DOP* DEHP 2- C O O * n- C 24 H 38 O CH 2 CH 2 CH 2 CH 3 CH (CH 2 ) % 2- A BHT , 4

CAS O C O * DOP* DEHP 2- C O O * n- C 24 H 38 O CH 2 CH 2 CH 2 CH 3 CH (CH 2 ) % 2- A BHT , 4 2-1 9628 31307 CAS 117817 2- O C O * DOP* DEHP 2- C O O * n- C 24 H 38 O 4 390.56 CH 2 CH 2 CH 2 CH 3 CH (CH 2 ) 3 1 99 % 2- ABHT 1. 2-55 3 3, 4 386 171 350 6 0.1 % d 20 4 0.9861 4 13.48 0.30410-4 Pa 2.2810-7

More information

1 2 D- D- 1206 D- D- -2003 120 /2004 D-FDA GRAS D D- 3 5 5 D- 75 10g/kg 14 40 20 D-101520 90 1520 20%101520 1520 D- 5(D- 2300-6700mg//) () 2024 615 D- 41220g/kg/ 1220g/kg/ 20g/kg/ 1220g/kg/ () 50 D- 10%

More information

040202PC用.doc

040202PC用.doc 15 48 15 8 25 15 1321 15 8 25 0825002 15 8 25 6 8 15 2 18 15 6 27 2 15 3 13 28 35 (1) 51 198 7 (2) 3 6 1 100g (1) 1 (1) 1 2 1 astaxanthin;3,3 -dihydroxy-, -carotene-4,4 -dione (2) 1 2 C40H52O4 596.86 97.0

More information

3, ,104 t mg/l 30 mg/l BOD mg 14 C 8, /kg 11 8, 1 11 OH = cm 3 / sec 11 OH /cm ppm

3, ,104 t mg/l 30 mg/l BOD mg 14 C 8, /kg 11 8, 1 11 OH = cm 3 / sec 11 OH /cm ppm 3, 3-1 200019 4800 CAS 91941 1138 3, 3-4, 4 - -3, 3 - H 2 N Cl Cl NH 2 C 12 H 10 C l2 N 2 253.13 1 95 1. 2 3, 4 132-133 402 5 >200 5 700kg/m 3 5 8.73 = 1 5.610-8 kpa 4.210-7 mmhg20 4 6 log Pow3.51 3.57

More information

CAS NC(CH 2 ) 4 CN 1,4- C 6 H 8 N c.c d = Pa

CAS NC(CH 2 ) 4 CN 1,4- C 6 H 8 N c.c d = Pa 1 200117 21512 CAS 111693 110 NC(CH 2 ) 4 CN 1,4- C 6 H 8 N 2 108.14 1 99 2-1. 2 1 295 159 c.c. 550 3 1.7-4.9 20 d 0.965 4 3.73 = 1 0.3 Pa 0.002 mmhg20 2 log Pow-0.32 m/z 41, 1.0 68 0.54 54 0.43 4 Koc9-16

More information

untitled

untitled Quantitative Risk Assessment on the Public Health Impact of Pathogenic Vibrio parahaemolyticus in Raw Oyster 1 15 5 23 48 2 21 1 16 1 16 1 11 3 1 3 4 23 1 2 16 12 16 5 6 Hazard IdentificationExposure

More information

t 492 t mg/l 30 mg/l BOD 95 OH = cm 3 / sec 25 8 OH /cm 3 12 = ph ph

t 492 t mg/l 30 mg/l BOD 95 OH = cm 3 / sec 25 8 OH /cm 3 12 = ph ph 2-1 200169 2740 CAS 110-49-6 1103 2- O H 3 C C O CH 2 CH 2 O CH 3 C 5 H 10 O 3 118.13 200168 2-1 99 2-1. 2 2, 3-65 2, 3 144145 45 o.c. 3 392 3 1.512.3 d19 1.009 2 4.07 = 1 30 Pa 0.23 mmhg20 2 4 log Pow0.10

More information

CAS H 3 C C CH 2 C 9 H tert d = hpa

CAS H 3 C C CH 2 C 9 H tert d = hpa 1 200140 35 CAS 98839 1335-2- H 3 C C CH 2 C 9 H 10 118.18 1 99 4-tert- 1. 2-23.2 2 163164 2 54 574 3 0.96.6 20 d 4 0.9082 2 4.07 = 1 2.5 hpa 1.9 mmhg20 2 4 log Pow3.48 3.44 m/z 118, 1.0 103 0.58 91 0.21

More information

橡三酸化二アンチモン.PDF

橡三酸化二アンチモン.PDF 1 2001 7 1 543( ) CAS 1309 64 4 1 25 ( ) Sb 2 O 3 291.52 1) 99 1. 2) 655 3) 1,425 3) ( ) 2) ( ) 2) ( ) 2) 5.2 ( ) 5.67 ( ) 3) 2) 2. 10 12,161 t ( 9,753 t 2,408 t) 4 2 1) 3. 1) 2) 3) 4. Selenastrum capricornutum

More information

橡フタル酸ブチルベンジル.PDF

橡フタル酸ブチルベンジル.PDF 1 97 7 3 1312 CAS 85 68 7 O BBP 1, 2- C 19 H 20 O 4 312.4 C C O O O (CH 2 ) 3 1 99.9 % 1. 2-35 3 2, 3 370 3, 4 199 d 25 4 1.117 2 10.8 = 1 5 1.15 10-3 Pa 8.6 10-6 mmhg 20 5 253 Pa 1.9 mmhg 200 5 log Pow

More information

橡99-24_00 アリルアルコール.PDF

橡99-24_00 アリルアルコール.PDF 1 9924 2260 CAS 107186 H 2 C CH CH 2 OH 2- -1- C 3 H 6 O 58.08 1 99 1. 2, 3 3, 4, 5-129 96-97 2 21c.c. 24o.c. 2 6, 7 378 6, 7 2.5-18 d 20 4 0.8540 2, 5 2.00 = 1 2.7 kpa 20 mmhg204.3 kpa 32 mmhg30 4 log

More information

(Pantothenic acid, C 9 H 17 NO 5, MW: CH 3 OH HOCH 2 C CHCONHCH 2 CH 2 COOH CH 3 (Calcium pantothenate, C 18 H 32 CaN 2 O 10, MW: ) CH 3

(Pantothenic acid, C 9 H 17 NO 5, MW: CH 3 OH HOCH 2 C CHCONHCH 2 CH 2 COOH CH 3 (Calcium pantothenate, C 18 H 32 CaN 2 O 10, MW: ) CH 3 (Pantothenic acid, C 9 H 17 NO 5, MW: 219.24 CH 3 OH HOCH 2 C CHCONHCH 2 CH 2 COOH CH 3 (Calcium pantothenate, C 18 H 32 CaN 2 O 10, MW: 476.54) CH 3 CH 3 OH HOOC 2 HC 2 HCHNOCHC C OCH 2 Ca OCH 2 C CHCONHCH

More information

,977 t 157,977 t mg l mg l BOD 9398 % OH = cm 3 / sec 11 = cm 3 / sec OH = /

,977 t 157,977 t mg l mg l BOD 9398 % OH = cm 3 / sec 11 = cm 3 / sec OH = / 1 9625 2219 CAS 75569 1, 2-1, 2- H 2 C CH CH 3 C 3 H 6 O 58.08 1 99 % 1. 2 2, 3-112.13 2, 3 34.23-37 449 2.8-37 % 2 d 0 4 0.859 4 d 20 0.8304 2 2, 4 2.00 = 1 53.33 kpa 400 mmhg18 59.33 kpa 445 mmhg20 5

More information

98-02.PDF

98-02.PDF 1 982 2207 CAS 67630 2- H 3 C H 3 C CH OH C 3 H 8 O 60.10 1 99.9 % n- 1. 2-88.5 3 82.5 3 11.7c.c. 455 4 212 d 20 4 0.78505 3 2.1 = 1 4 4.4 kpa 33 mmhg20 4 log Pow0.05 0.07 5 m/z45, 1.0 43 0.19 27 0.17

More information

untitled

untitled ORYZA POLYAMINE ORYZA POLYAMINE -P -PC -LC 1. Ver.1.0 MM ver. 1.0MM 1) Roseeuw D.I. et al., Epidermal keratinocytes actively maintain their intracellular polyamine levels. Cell Tissue Kinet. 16, 493-504

More information

橡アジポニトリル.PDF

橡アジポニトリル.PDF 1 200117 21512( ) CAS 111693 110( ) 1,4- NC(CH 2 ) 4 CN C 6 H 8 N 2 108.14 1) 99 2-1. 2) 1 2) 295 2) 159(c.c.) 3) 550 3) 1.7-4.9 vol % ( ) 3) d 20 0.965 2) 3.73 ( = 1) 4 0.3 Pa (0.002 mmhg) (20) 2) log

More information

環境基準項目等の設定根拠等

環境基準項目等の設定根拠等 7440-43-9 Cd 112.4 ph (CdCl 2 ) (CdO) (CdSO 4 ) 80 8.6 4.1 6.95 4.7 75.5g/100ml (0) 2,471,566t( ) 12 251kg( ) 3,916,204kg( ) (1) 0.01mg/l 0.0310g/l 0.01mg/l 60 (2) 0.003mg/l 0.005mg/l 0.005mg/l 0.01mg/l

More information

Fig. ph Si-O-Na H O Si- Na OH Si-O-Si OH Si-O Si-OH Si-O-Si Si-O Si-O Si-OH Si-OH Si-O-Si H O 6

Fig. ph Si-O-Na H O Si- Na OH Si-O-Si OH Si-O Si-OH Si-O-Si Si-O Si-O Si-OH Si-OH Si-O-Si H O 6 NMR ESR NMR 5 Fig. ph Si-O-Na H O Si- Na OH Si-O-Si OH Si-O Si-OH Si-O-Si Si-O Si-O Si-OH Si-OH Si-O-Si H O 6 Fig. (a) Na O-B -Si Na O-B Si Fig. (b) Na O-CaO-SiO Na O-CaO-B -Si. Na O-. CaO-. Si -. Al O

More information

Fig. 1 Chemical structure of DL-8280

Fig. 1 Chemical structure of DL-8280 Fig. 1 Chemical structure of DL-8280 Fig. 2 Susceptibility of cl in ical isolates to DL4280 Fig. 5 Susceptibility of clinical isolates to DL-8280 Fig. 3 Susceptibility of clinical isolates to DL-8280 Fig.

More information

添加物評価書 ケイ酸カルシウム ( 第 2 版 ) 2015 年 1 月 食品安全委員会

添加物評価書 ケイ酸カルシウム ( 第 2 版 ) 2015 年 1 月 食品安全委員会 添加物評価書 ケイ酸カルシウム ( 第 2 版 ) 2015 年 1 月 食品安全委員会 目次 頁 審議の経緯... 3 食品安全委員会委員名簿... 4 食品安全委員会添加物専門調査会専門委員名簿... 5 要約... 6 Ⅰ. 評価対象品目の概要... 8 1. 用途... 8 2. 主成分の名称... 8 3. 組成 組成式及び式量... 8 4. 性状等... 8 5. 起源又は発見の経緯等...

More information

第1章 溶接法および機器

第1章 溶接法および機器 670 ) ) ) ) 2.1 ) 42 671 Sn T m K. T m. T m. T m 2.2 JIS BAl BPd Al-Si Al-Mn KAlF -K AlF H O Ni 43 672 Sn-In Zn EU RoHS ) Pb Cd Hg JIS Z ( ) ) ) 3.1 44 673. MO HX MX H O M X (d) Young sf lf cos sl sf lf

More information

化学物質の環境リスク初期評価(平成9~12年度)結果[39物質]

化学物質の環境リスク初期評価(平成9~12年度)結果[39物質] (1) CAS 302-01-2 N 2 H 4 32.0 CAS 7803-57-8 2 1) 2.0 2,3) 113.5 2,4) 1.011 (15 ) 2,3) 1.0036 (25 ) 2,4) 2.1 kpa (16 mmhg) (20 ) 3) 1ppm=1.31 mg/m 3 at 25, n- / -1.37 ( ) 3) 5) K b1 8.510-7 K b2 8.910-16

More information

橡96-01.PDF

橡96-01.PDF 1 961 31 CAS 71432 C 6 H 6 78.11 1) 99 % 1. 5.5 2) 80.1 2) -11 3) 293563 3) 1.48.0% 3) d 20 0.8786 4) 2.77 ( = 1) 4) 4 13.33 kpa (100 mmhg) (26.9) 2) log Pow2.13 ( ) 5) 2.14 ( ) 6) m/z78 ( 1.0 )77 ( 0.20

More information

報告書 H22-2A-09

報告書 H22-2A-09 061-0293 1757 TEL 0133-23-1211 2.0% 0.5% in vitro QOL Quality of Life 1 MCE-400 400 mpa s Duck Algin 350M M/G 0.8 70 80 C 20% 50 C 1.0% 5 C SV-10 5 C 10 ml E TV 20H model E 1 34 R24 1 ml 5 C 30 6 12 30

More information

untitled

untitled 1 2 3 http://www.info.pmda.go.jp/ 4 5 6 7 8 9 10 11 (Quincke s edema) 12 13 梗 疼 () 14 15 J Allergy Clin Immunol 115;S483-S523, 2005 16 17 IgE IgE IgE 18 19 20 21 腿 22 Hydrocortisone 100 200 mg 5 mg/kg

More information

1 I ( )

1 I ( ) 1 I. 3 1. 4 2. 6 3. 7 4. 8 4.1 8 4.2 ( ) 9 4.3 13 4.4 16 4.5 17 5. 19 5.1 20 5.2 25 5.3 33 6. 37 6.1 37 6.2 41 6.3 44 7. 46 7.1 46 7.2 47 II. 48 A 50 1 50 2 51 3 56 4 59 60 B 61 1 61 2 62 3 65 4 67 68

More information

http://www.who.int/ipcs/publications/ehc/en/index.html EHC 1 2 3 4 / EHC http://www.nihs.go.jp/dcbi/publist/ehchsg/ 1-8) WHO/IPCS CICAD (Concise Inter

http://www.who.int/ipcs/publications/ehc/en/index.html EHC 1 2 3 4 / EHC http://www.nihs.go.jp/dcbi/publist/ehchsg/ 1-8) WHO/IPCS CICAD (Concise Inter 3 [ ] Priority IARC JMPR 2004 10 Priority 1 Priority 1 Priority 2 Priority 3 Priority 1 1-1) CERI) http://www.cerij.or.jp/ceri_jp/koukai/sheet/sheet_indx4.htm http://www.safe.nite.go.jp/data/sougou/pk_list.html?table_name=hyoka&rank=sh

More information

特論2

特論2 Bull. Natl. Inst. Health Sci., 124 Special report Hazardous Food-Borne Fungi, and the Present and Future Approaches to the Mycotoxin Regulations in Japan CladosporiumPecinilliumAspergillus 17 1,545 1,065

More information

untitled

untitled RYZA IL & FAT CHEMICAL C., LTD. SAKURA EXTRACT Ver.1.4MK Ver. 1.4MK 1) 1300 1929 1 Ver. 1.4MK Sakura 1-caffeoyl---D-glucopyranoside quercetin 3---D-glucopyranoside 1) :, 4, 11-22 (1995). 2 Ver. 1.4MK 3

More information

356 Nippon Shokuhin Kagaku Kogaku Kaishi Vol. /., No.1, -/0-0+ (,**1) 44 For Quality Control and Quality Assurance in Food Analysis Akemi Yasui Analyt

356 Nippon Shokuhin Kagaku Kogaku Kaishi Vol. /., No.1, -/0-0+ (,**1) 44 For Quality Control and Quality Assurance in Food Analysis Akemi Yasui Analyt 356 Nippon Shokuhin Kagaku Kogaku Kaishi Vol. /., No.1, -/0-0 (,**1) 44 For Quality Control and Quality Assurance in Food Analysis Akemi Yasui Analytical Science Division, National Food Research Institute,

More information

平成26年度 化学物質分析法開発報告書

平成26年度 化学物質分析法開発報告書 N,N- N,N-Dimethylacetamide Acethyldimethylamine CAS 127-19-5 C 4 H 9 NO 87.12 ~ 87.14 87.68413 163-165 C 1) - 18.59 C 2) 1 mg/l 25 C 3) 3.3 hpa 2 C 4) log P ow -.77 2).9429 2/4 C 1) 3.1 4) 1.31E - 8 atm-m

More information

untitled

untitled 1 1 1 2 2 2 2 2 3 3 3 5 5 5 5 6 8 9 11 12 12 12 12 13 14 FAO/WHO JECFA 14 EU 14 14 15 16 HPMC 20 L-HPC 22 MC CMC-Na HPMCP HPMCAS HPMCHM-HPMC - 1 - HPMC MC 2- CMC-Na CMC-Ca HPMC 15 2003 6 GMPGood Manufacturing

More information

988 CHEMOTHERAPY NOV. 1971

988 CHEMOTHERAPY NOV. 1971 988 CHEMOTHERAPY NOV. 1971 VOL. 19 NO. 8 CHEMOTHERAPY 989 Effect of medium-ph and inoculum size on activity of SB-PC heart infusion agar, mcg/ml Sensitivity distribution of Staphylococci to SB-PC in surgical

More information

参考資料5 農薬評価書 メタアルデヒド(食品安全委員会資料)

参考資料5 農薬評価書 メタアルデヒド(食品安全委員会資料) 1 3 3 4 5. 6 1. 6 2. 6 3. 6 4. 6 5. 6 6. 6 7. 6. 7 1. 7 2. 8 (1) 8 (2) 9 (3) 9 (4) 10 (5) 10 3. 11 (1) 11 (2) 11 (3) 11 (4) 12 4. 12 (1) 12 (2) 12 (3) 13 5. 13 6. 13 7. 14 8. 15 9. 16 10. 16 (1) 90 16-1

More information

10-7 cm/ 50cm 10-6 cm/ 2,4-D 2 ph

10-7 cm/ 50cm 10-6 cm/ 2,4-D 2 ph 10-7 cm/ 50cm 10-6 cm/ 2,4-D 2 ph Cd 2+ Ca 2+ - Cr(OH) 4 ph ph ph ph 6 CrO 2-4 AsO 3-4 ph 9 Cd 2+ ph 6 ph 9 ph 6 9 ph B(OH) - 4 ph B(OH) 3 ph ph B(OH) - 4 ph soil organic matter ph ph ph ph 2,4-D ph 2,4-D

More information

Key words : Adverse reactions, Egg allergy, IgG antibody, Mills allergy, FAST

Key words : Adverse reactions, Egg allergy, IgG antibody, Mills allergy, FAST Key words : Adverse reactions, Egg allergy, IgG antibody, Mills allergy, FAST 13) Danaeus, A., Johansson, S. G. O., Foucard, T. & Ohman, S.: Clinical and immunogical aspects of food allergy in childhood.

More information

The Heart Healthy Tocotrienol Complex Tocomin SupraBio

The Heart Healthy Tocotrienol Complex Tocomin SupraBio The Heart Healthy Tocotrienol Complex Tocomin SupraBio The Heart Healthy Tocotrienol Complex Tocomin SupraBio 1. Fact Sheet No. 317; World Health Organization (WHO), 2007 2. LLOYD-JONES D. et al. Circulation

More information

CHEMOTHERAPY FEB Table 1 Background of volunteers

CHEMOTHERAPY FEB Table 1 Background of volunteers CHEMOTHERAPY FEB. 1985 Table 1 Background of volunteers Table 3 Reproducibility of saisomicln In the EIA and the RIA Fig.1 Comparison of the EIA with the RIA or bioassay of sisomicin Table 4 Blood levels

More information

0 0 0 0............ PNEC.............................. PNECsed.................. 0 0 0 0 PNEC logpow. * Oncorhynchus mykisslc0. mg/l UFs0,000 0.000 mg/l0. µg/lpnec PNECwater PNECwater * Sangster, J. ()

More information

untitled

untitled 1% 1 mg 1 mg 2 CTD 6 Section 2.6.1 Introduction 2.6.1 H 1 descarboethoxyloratadinesch 34117 7.9 SCH 34117 2.6.1-1 O OC 2 H 5 Cl N N JAN Loratadine (JANINN) ethyl 4-(8-chloro-5,6-dihydro-11H-benzo[5,6]

More information

gofman2.eps

gofman2.eps 2011 7 10 4 7 1 ICRP(2007) 5.7 10 2 Sv 1 1 13 (=4600 =11 =660 ) 10mSv 5.7 10 4 4600[] =2.6[] ICRP 0 1 licrp 1 2 1 DDREF ICRP(2007) (ICRP 2007, p.178) - (idem., p.174) 1Sv - (DDREF: dose and dose-rate effectiveness

More information

000..\..

000..\.. Bull. Nagoya Univ. Museum No. 20, 79 91, 2004 Quantitative chemical analysis of rocks with X-ray fluorescence analyzer XRF-1800 NAKAZAKI Mineko TSUBOI Motohiro KANAGAWA Kazuyo KATO Takenori SUZUKI Kazuhiro

More information

エコリシン点眼液/眼軟膏インタビューフォーム

エコリシン点眼液/眼軟膏インタビューフォーム 2011 11 4 871319 1mL 5mg 5mg15 1g 5mg 5mg15 JAN JAN Erythromycin LactobionateJAN Colistin Sodium MethanesulfonateJAN 1970 3 31 1970 8 1 1970 7 20 TEL0120-921-839 06-6321-7056 9 17 https://www.santen.co.jp/medical/admin/a300.jsp

More information

医療事故の現状と課題-医療事故への対応策の整備を中心に-

医療事故の現状と課題-医療事故への対応策の整備を中心に- 1 2 1 2 3 1 2 3 1 I II 1 1 1993 5 442 2002 896 10 1 5 14 http://courtdomino2.courts.go.jp/shanyou.nsf/0258b7a1680aa82849256467004875a6/352546364a541 14049256d5c000dde7f?OpenDocument 22% 2 3 4 5 2 6 1997

More information

Table 1 Components of corn dietary fibers

Table 1 Components of corn dietary fibers Effects of Purified Corn Dietary Fiber on Blood Glucose, and Serum and Liver Lipids in Normal Rats and Mice Sachie Ikegami *1, Saeko Ohsawa *1, Shouko Machida *2 and Akiko Hada *2 The National Institute

More information

寄稿論文 高い発ガン活性を示す鉄キレートお構造特性 | 東京化成工業

寄稿論文 高い発ガン活性を示す鉄キレートお構造特性 | 東京化成工業 NTBI = nontransferrin-bound iron NTBI DNA H DNA 2 NTBI NTBI NTBI NTBI NTBI NTBI (nta) (nta) (nta) NTBI (nta) (nta) NTBI (nta)ntbi Fe-(nta) (nta) N(CH 2 CH) 3 HCCH 2 NHCH 2 CH 2 NHCH 2 CH (HCCH 2 ) 2 NH

More information

JIS A 5308 a1 moll moll moll (JP) REAGENT CHEMICALS ninth edition ACS SPECIFICATIONS Replication Duplicate standardiz

JIS A 5308 a1 moll moll moll (JP) REAGENT CHEMICALS ninth edition ACS SPECIFICATIONS Replication Duplicate standardiz Measurement Uncertainty MU 1 mol/l JIS A 5308 a1 moll 1.0000.010 moll 0.001 moll (JP) 4 3 3 0.001 0.1 REAGENT CHEMICALS ninth edition ACS SPECIFICATIONS Replication Duplicate standardizations for solutions

More information

(Ⅱ)化学物質の環境リスク初期評価(13物質)の結果

(Ⅱ)化学物質の環境リスク初期評価(13物質)の結果 1 ( ) DBDPO CAS 1163-19-5 C 12 Br 10 O 959.2 2 1) 305 2) 3.0 1) 1- / (logp ow ) 1) 5.03 mmhg306 1) 1) 3) 4) 5) 1.010-4 6) mg/l25 3 7) OH 8) 4 9) 6 BOD 0% 14 100 mg/l 30 7) 10) BCF 5 < 42 60 mg/l 7) 50

More information

Effect of Trimoprostil on Gastric Secretion Takeshi KAWAMURA * Hiroko EBINA * Fumiaki KOIZUMI * and Akira ISHIMORI * *Department of Clinical and Labor

Effect of Trimoprostil on Gastric Secretion Takeshi KAWAMURA * Hiroko EBINA * Fumiaki KOIZUMI * and Akira ISHIMORI * *Department of Clinical and Labor Effect of Trimoprostil on Gastric Secretion Takeshi KAWAMURA * Hiroko EBINA * Fumiaki KOIZUMI * and Akira ISHIMORI * *Department of Clinical and Laboratory Medicine University School of Medicine, Tohoku

More information

資料1(目消し版).ppt

資料1(目消し版).ppt 1 Dr. Grandjean 2 15 45 3 4 CH 3 Hg + Hg 0 fi Hg ++ fich 3 + MeHg MeHg 5 Methylmercury-2 6 :, A. Yasutake 7 - A. Yasutake 8 :,. A. Yasutake 9 A. Yasutake 10 (%) : : : : : MeHg 0.05 250 : 2 : 1 : 0.1 :

More information

untitled

untitled 2 3-2-1 RIA 2 RIA 1 RIA 2 2 1 3-2-2 RIA OMB CAO 3-2-3 OMB OIRA Office of Information and Regulatory Affairs RIA 12866 RIA OIRA's review of a draft regulation OMB 12866 Return Letters OMB Prompt Letters

More information

No.7, (2006) A Survey of Legislation Regarding Environmental Information in Europe and Japan IWATA Motokazu Nihon University, Graduate School of

No.7, (2006) A Survey of Legislation Regarding Environmental Information in Europe and Japan IWATA Motokazu Nihon University, Graduate School of No.7, 35-44 (2006) A Survey of Legislation Regarding Environmental Information in Europe and Japan IWATA Motokazu Nihon University, Graduate School of Social and Cultural Studies As Principle 10 of the

More information

Jan THE JAPANESE JOURNAL OF ANTIBIOTICS XL-1 Table 1. Outline of administering doses, routes and sampling times *: 4 ml/hr/kg Bacillus subtilis

Jan THE JAPANESE JOURNAL OF ANTIBIOTICS XL-1 Table 1. Outline of administering doses, routes and sampling times *: 4 ml/hr/kg Bacillus subtilis THE JAPANESE JOURNAL OF ANTIBIOTICS XL-1 Jan. 1987 Jan. 1987 THE JAPANESE JOURNAL OF ANTIBIOTICS XL-1 Table 1. Outline of administering doses, routes and sampling times *: 4 ml/hr/kg Bacillus subtilis

More information

12 40 7 1995 9 11 12 5 10 5 8 9 6 10 7 19 20 100 1 2 3 4 31 1956 5 28 1953 12 54 17 32 1957 40 1965 5 40 1965 7 26 5 5 11 1999 2,263 40 895 11 1999 690 352 7 1995 12 11,152 10,353 799 28 1953 1 6 31

More information

リスクコミュニケーション概論

リスクコミュニケーション概論 1 2005 7 2 http://hideyukihirakawa.com/ Contents 1. 2. 3. 4. 2 1. (Alvin Weinberg, 1972) e.g. etc 3 4 2. 5 NRC, 1989; Codex, 2004 ( ) ( ) NGO 6 2 (TRUSTNET: Dubreuil et al, 2002) www.trustnetgovernance.com

More information

DNA

DNA 1 1 1. 1 2. 2 3. 2 4. 2 2 1. 2 4 5 7 2. 7 3. DNA 8 4. 10 13 Plasmodium (P. falciparum) (P. vivax) (P. malariae) P. ovale 4 40% 200 7 40 48 72 1. - 1 - 2. DNA 3 3. 1) 2) 3) 4) 4. 1 1) - 2 - 2) EDTA 1) 1

More information

untitled

untitled 254nm UV TiO 2 20nm :Sr 5 Ta 4 O 15 3 4 KEY-1 KEY-2 (Ti,Nb,Ta) 5 KEY-1 KEY-2 6 7 NiO/ Sr 2 Ta 2 O 7 mmol h -1 g -1 20 15 10 5 H 2 O 2 H 2 O 2 0 0 2 4 6 8 10 12 NiO/Sr 2 Ta 2 O 7 The synthesis of photocatalysts

More information

Fig. 1. Structure of [methyl-14c]zonisamide

Fig. 1. Structure of [methyl-14c]zonisamide Key words : Zonisamide, Metabolism, Plasma, Erythrocytes, Preputial gland, Urine, Bile, Rat, Dog, Monkey Metabolism of ["Clzonisamide in rats, dogs and monkeys Katashi MATSUMOTO, Koji YOSHIDA, Toshihiko

More information

Effect of Sympathetic and parasympathetic agents on cholesterol metabolism in mice salivary glands. Eriko, NEZU and Haruo, NAKAMURA (Department of Ora

Effect of Sympathetic and parasympathetic agents on cholesterol metabolism in mice salivary glands. Eriko, NEZU and Haruo, NAKAMURA (Department of Ora Effect of Sympathetic and parasympathetic agents on cholesterol metabolism in mice salivary glands. Eriko, NEZU and Haruo, NAKAMURA (Department of Oral Physiology, Hokkaido University School of Dentistry,

More information

化学物質の内分泌かく乱作用に関する環境省の今後の対応方針について

化学物質の内分泌かく乱作用に関する環境省の今後の対応方針について ExTEND2005 2005 3 ExTEND2005 Enhanced Tack on Endocrine Disruption 10 (1998 )5 - SPEED'98-12 (2000 )11 2000 11 ( SPEED'98 ) 14 (2002 )8 (WHO)/ (ILO)/ (UNEP) Global Assessment of the State-of-the-Science

More information

1 見出し1,12ポ,日本語ゴシック,英語Arial,段落後は6ポの設定です

1 見出し1,12ポ,日本語ゴシック,英語Arial,段落後は6ポの設定です 8. Page1 8. B 1 5) 6) 2099 2370 50 400 mg 19 (1) 1) (a) 78.9% 30/38 4 3 35.7% 5/14 71.4% 10/1485.7% 12/142 1 83.3% 5/63 2 1 1 1 8. Page2 (b) 2099 1897 82.4% 1562/1897 2 84.0% 1298/1545 3 2 80.4% 472/58779.0%

More information

47 Nippon Shokuhin Kagaku Kogaku Kaishi Vol. /., No.++, /*3 /+/ (,**1) 509 Current Situation on Tran Fatty Acid Issues Tadahiro Nagata Department of H

47 Nippon Shokuhin Kagaku Kogaku Kaishi Vol. /., No.++, /*3 /+/ (,**1) 509 Current Situation on Tran Fatty Acid Issues Tadahiro Nagata Department of H 47 Nippon Shokuhin Kagaku Kogaku Kaishi Vol. /., No.++, /*3/+/ (,**1) 509 Current Situation on Tran Fatty Acid Issues Tadahiro Nagata Department of Human Nutrition, Seitoku University, //* Iwase, Matsudo,

More information

JAJP

JAJP Agilent 7500ce ORS ICP-MS Glenn Woods Agilent Technologies Ltd. 5500 Lakeside, Cheadle Royal Business Park Stockport UK Agilent 7500ce ICP-MS 5 7500ce (ORS) 1 ORS 7500ce ORS ICP-MS ( ) 7500 ICP-MS (27.12

More information

CHEMOTHERAPY JUNE 1993 Table 1. Background of patients in pharmacokinetic study

CHEMOTHERAPY JUNE 1993 Table 1. Background of patients in pharmacokinetic study CHEMOTHERAPY JUNE 1993 Table 1. Background of patients in pharmacokinetic study VOL. 41 S 1 Table 2. Levels (Đg/ml or Đg/g) of S-1006 in serum, bile, and tissue (gallbladder) after oral administration

More information

スライド タイトルなし

スライド タイトルなし 2003.11.25 JEMS/BMS 2 N H C C C NH 2 Furylfuramide (AF-2) Dibenzo[a, l ]pyrene ( DBP) PAH Mutant Frequencies of lacz and cii gene Induced by DBP and AF2 600 500 400 cii lacz cii lacz 300 200 100 0 Liver

More information

jsfm_著者紹介_160520

jsfm_著者紹介_160520 Sarah M. A. Caney 1 European Journal of Companion Animal Practice (2015) Autumn 25 (3) EJCAP 25(3) Special issue 2015 P4 Commissioned paper* Management of the elderly cat Sarah M. A. Caney 1-01 - EJCAP

More information

Candida albicans In Vitro Diagnostics (13)--D-Glucan Determination Reagents

Candida albicans In Vitro Diagnostics (13)--D-Glucan Determination Reagents D 012 Candida albicans In Vitro Diagnostics (13)--D-Glucan Determination Reagents DATA : 1 DATA : 2 3 DATA : UNGITEC 1 1 DATA : 20pg/mL 1020pg/mL 10pg/mL (cut off 20pg/mL) 90.2%(37/41) 100%(85/85) 96.8%(122/126)

More information

VOL. 23 NO. 3 CHEMOTHERAPY 1067 Table 2 Sensitivity of gram positive cocci isolated from various diagnostic materials Table 3 Sensitivity of gram nega

VOL. 23 NO. 3 CHEMOTHERAPY 1067 Table 2 Sensitivity of gram positive cocci isolated from various diagnostic materials Table 3 Sensitivity of gram nega 1066 CHEMOTHERAPY MAR. 1975 Table 1 Sensitivity of standard strains VOL. 23 NO. 3 CHEMOTHERAPY 1067 Table 2 Sensitivity of gram positive cocci isolated from various diagnostic materials Table 3 Sensitivity

More information

19) Pearson, J., Southam, G. G. and Holley, R. A.: Survival and transport of bacteria in egg washwater. Appl. Environ. Microbiol., 53, 2060-2065 (1987). 20) Poovaiah, B. W.: Role of calcium in prolonging

More information

(1) (2) (1) (2) (1) Seg (2) Seg (3) Seg (4) Seg (1) (2) (3) ( ) (1) (PCA)...12

(1) (2) (1) (2) (1) Seg (2) Seg (3) Seg (4) Seg (1) (2) (3) ( ) (1) (PCA)...12 (1)...109 (2)...110 (1) 28...111 (2) 28...113 (1) Seg...115 (2) Seg...117 (3) Seg...119 (4) Seg...120 (1)...122 (2)...122 (3) ( )...126 (1) (PCA)...127 (2) Draize...128 (1) Ames...129 2 in vitro...132

More information

32 1 BRONJ BRONJ II BRONJ BRONJ 4 BP BRONJ 6 1 III BP BRONJ

32 1 BRONJ BRONJ II BRONJ BRONJ 4 BP BRONJ 6 1 III BP BRONJ 29 1 31 40 2014 31 Bisphosphonate related osteonecrosis of jaw; BRONJ 2008 4 2012 3 36 98 8 11 19 BRONJ 0 13 2 5 3 1 1 0 BP 4 15 10 5 α-streptococcus 0 BRONJ BRONJ BP I Paget 1 409-3898 1110 2014 1 27

More information

ナノ材料の有害性評価

ナノ材料の有害性評価 CRM CRM 181 TG424 TG42419971995TG407 PBPK PBPK DNA DNA PBPK C C art vein Ramsey & Andersen (1984) ( Qalv Cinh Qt Cvein ) ( Qt Qalv PN ) = + + { ( )} Qi Ci = i Pi ( C ) art Ci dai dt = Qi Qt Pi ( C ) art

More information

Huawei G6-L22 QSG-V100R001_02

Huawei  G6-L22 QSG-V100R001_02 G6 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 1 2 3 17 4 5 18 UI 100% 8:08 19 100% 8:08 20 100% 8:08 21 100% 8:08 22 100% 8:08 ********** 23 100% 8:08 Happy birthday! 24 S S 25 100% 8:08 26 http://consumer.huawei.com/jp/

More information

A5 PDF.pwd

A5 PDF.pwd Global Reporting Initiative GRI 2013 International Integrated Reporting Council: IIRC IIRC 2013 European Union: EU European Parliament and the Council of the European Union 2014 Public Interest EntitiesPIE

More information

IF MR 63 2 IF 10 3 IF IF IF A4 9 IF IF IF 11 1 IF IF IF MR IF IF MR Drug Safety Update IF

IF MR 63 2 IF 10 3 IF IF IF A4 9 IF IF IF 11 1 IF IF IF MR IF IF MR Drug Safety Update IF 2009 2 1 872612 IF 1998 9 IODINE M DISINFECTANT SOLUTION 10 10w/v 100mL 10g( 1g) PovidoneIodine 2008 10 15 2008 12 19 2009 1 6 IF 2008 12 IF MR 63 2 IF 10 3 IF IF IF A4 9 IF IF IF 11 1 IF IF IF MR IF IF

More information

橡H8フィリピン報告書_日本語) PDF

橡H8フィリピン報告書_日本語) PDF 1 2 7,000 7,000 3 1986 Execut ive Order 192 Depart ment of Environment and Natural Resources Department of Natural Resources Ministry of House Settlements 8 4 8 6 4 35,000 5,000 30,000 7,000 192 Environmental

More information

ver5.1 HS 1. ALPHA LIPOIC ACID () S S COOH HS 1. α - SH COOH - ( 1) CoA -( 2)- - --P80 (--WSP8-L1-WSPC8 -LC1) - 1

ver5.1 HS 1. ALPHA LIPOIC ACID () S S COOH HS 1. α - SH COOH - ( 1) CoA -( 2)- - --P80 (--WSP8-L1-WSPC8 -LC1) - 1 ORYZA OIL & FAT CHEMICAL CO., LTD. ALPHA LIPOIC ACID --P () --P80 () --WSP8 () --L1 () --PC () --PC80 () --WSPC8 () --LC1 () ver. 5.1HS ver5.1 HS 1. ALPHA LIPOIC ACID 16 3 31 0331009 - () 19 5 24 0524001

More information

20mg CTD 2.4 2.4 2.4... 5 2.4.1... 5 2.4.2... 7 2.4.3... 10 2.4.4... 13 2.4.5... 18 2.4.6... 20 3 2.4 2.4 2.4.1 JNS002 ( HSPC) N-(Carbonyl-methoxypolyethylene glycol 2000)-1,2- distearoyl-sn-glycero-3-phosphoethanolamine

More information

Atlas_j060419

Atlas_j060419 Hill s Atlas of Veterinary Clinical Anatomy 1 29 30 2 3 4 5 31 32 33 34 35 36 37 6 7 8 9 10 11 12 13 38 39 40 41 14 15 16 17 18 19 20 21 22 23 24 25 26 27 42 43 44 45 46 47 48 49 50 51 52 53 54 55 28 81

More information

後期化学_01_濃度

後期化学_01_濃度 2011 ( ) 1 4 1 100 g g % * 1 100 g 1 g 1 % * 2 (1 g)/(100 g) = 0.01 = 1 % 100 g 100 g 99 g 100 g 1 g 1 % 2.5 g 50 g (2.5 g)/(50 g) = 0.050 = 5.0 % 100 ml g 1 %(w/w) wt% % %(w/v) % / 2 % SI 2 / % 100 ml

More information

VOL. 36 S-3 CHEMOTHERAPY 437

VOL. 36 S-3 CHEMOTHERAPY 437 VOL. 36 S-3 CHEMOTHERAPY 437 438 CHEMOTHERAPY JULY 1988 Fig. 1 Contractile response of gastrointestinal tract to intravenous administration of saline and EM in interdigestive state in dogs (a) : Saline,

More information

CHEMOTHERAPY JUNE 1988 ( })-1-ethyl-6,8-difluoro-1,4-dihydro-7-(3-methyl-l-piperaziny1) 4-oxo-3-quinolinecarboxylic acid hydrochloride Fig. 1. Chemica

CHEMOTHERAPY JUNE 1988 ( })-1-ethyl-6,8-difluoro-1,4-dihydro-7-(3-methyl-l-piperaziny1) 4-oxo-3-quinolinecarboxylic acid hydrochloride Fig. 1. Chemica CHEMOTHERAPY JUNE 1988 ( })-1-ethyl-6,8-difluoro-1,4-dihydro-7-(3-methyl-l-piperaziny1) 4-oxo-3-quinolinecarboxylic acid hydrochloride Fig. 1. Chemical structure of NY-198 VOL. 36 5-2 CHEMOTHERAPY Mouse

More information

% 1% SEM-EDX - X Si Ca SEM-EDX SIMS ppm % M M T 100 % 100 % Ba 1 % 91 % 9 % 9 % 1 % 87 % 13 % 13 % 1 % 64 % 36 % 36 % 1 % 34 46

% 1% SEM-EDX - X Si Ca SEM-EDX SIMS ppm % M M T 100 % 100 % Ba 1 % 91 % 9 % 9 % 1 % 87 % 13 % 13 % 1 % 64 % 36 % 36 % 1 % 34 46 Review on Hair Analysis in the Wakayama Arsenic Case Jun KAWAI Department of Materials Science and Engineering, Kyoto University Sakyo-ku, Kyoto 606-8501, Japan Received 6 December 2014, Revised 29 December

More information

Contents 4 06 IP2 41 Thermo Scientific Nalgene Nalgene

Contents 4 06 IP2 41 Thermo Scientific Nalgene Nalgene Nalgene & Packaging plastic Bottles & Vials Contents 4 06 IP2 41 Thermo Scientific Nalgene 5 07 42 8 08 43 9 09 45 11 10 46 Nalgene 12 11 50 13 12 53 01 20 13 61 02 28 14 64 03 33 15 66 04 37 16 / 67 05

More information

Table 1 Patients with various renal function * Ccr, Creatinine clearance ml/min per 1. 48 m2 ** C.V.D., Cerebral vascular disease ; C.R F., Chronic renal failure ; H.D., Hemoclialysis ; D., Dialyzer ;

More information

2010 1 1 7 2 16 2 2 06in 3 3 錆 錆 06in 4 4 0.1 5 5 HCl Cl NaOH H Cl O 2 H H 2 O NaCl Na OH H 2 O NaCl 2010 6 6 ph3.0 30 mg/l 30 1 O-157 H7 2010 7 7 100 Cl 80 60 40 20 HClO ClO CL ph 10 100,000ppm 12 01

More information

RAA-05(201604)MRA対応製品ver6

RAA-05(201604)MRA対応製品ver6 M R A 対 応 製 品 ISO/IEC 17025 ISO/IEC 17025は 試験所及び校正機関が特定の試験又は 校正を実施する能力があるものとして認定を 受けようとする場合の一般要求事項を規定した国際規格 国際相互承認 MRA Mutual Recognition Arrangement 相互承認協定 とは 試験 検査を実施する試験所 検査機関を認定する国際組織として ILAC 国際試験所認定協力機構

More information

Report of Special Research from the National Institute for Environmental Studies, Japan NATIONAL INSTITUTE FOR ENVIRONMENTAL STUDIES

Report of Special Research from the National Institute for Environmental Studies, Japan NATIONAL INSTITUTE FOR ENVIRONMENTAL STUDIES Report of Special Research from the National Institute for Environmental Studies, Japan NATIONAL INSTITUTE FOR ENVIRONMENTAL STUDIES ) V O Cvolatile organic compounds V O C V O C 1940 10 1 1 N Ox V

More information

Juntendo Medical Journal

Juntendo Medical Journal The hair growth effect of minoxidil Susumu OTOMO, Ph. D. Key words : minoxidil, minoxidil sulfate, hair growth, K+-channel opener, male pattern baldness Dept. of Pharmacology, Research Center Taisho Pharmaceutical

More information

1999年3月作成(新様式第1版) 

1999年3月作成(新様式第1版)  200622 19989 871313 1mL4mg JAN oxybuprocaine hydrochloridejan 2002621 20037 4 19667 1 FAX 2005 10 29607 05 1 63 () 103 2 3 49 111 4 Drug Safety Update 1. -------------------------------------1 2. -----------------------1

More information

AUTONOMIC FUNCTIONAL STATE IN RENAL TUBERCULOSIS REPORT III. SERUM CHOLINESTERASE ACTIVITY IN RENAL TUBERCULOSIS Sanai Yamamura The Department of Urol

AUTONOMIC FUNCTIONAL STATE IN RENAL TUBERCULOSIS REPORT III. SERUM CHOLINESTERASE ACTIVITY IN RENAL TUBERCULOSIS Sanai Yamamura The Department of Urol AUTONOMIC FUNCTIONAL STATE IN RENAL TUBERCULOSIS REPORT III. SERUM CHOLINESTERASE ACTIVITY IN RENAL TUBERCULOSIS Sanai Yamamura The Department of Urology, Kumamoto University College of Medicine (Director:

More information

Radiation induced colour centres in vitreous systems Stevels, J.M. Published in: Yogyo Kyokaishi Gepubliceerd: 01/01/1967 Document Version Uitgevers PDF, ook bekend als Version of Record Please check the

More information

Analysis of Hypoxia Dynamics Using Pelagic and Benthic Biogeochemical Model: Focus on the Formation and Release of Hydrogen Sulfide Masayasu IRIE, Shu

Analysis of Hypoxia Dynamics Using Pelagic and Benthic Biogeochemical Model: Focus on the Formation and Release of Hydrogen Sulfide Masayasu IRIE, Shu Analysis of Hypoxia Dynamics Using Pelagic and Benthic Biogeochemical Model: Focus on the Formation and Release of Hydrogen Sulfide Masayasu IRIE, Shuzo NISHIDA, Kyosuke TERANAKA, Yohei TSUJI Mitsunari

More information